Heart drug cuts Alzheimer's risk in Cambridge breakthrough
A groundbreaking study from the University of Cambridge reveals that a widely prescribed blood pressure medication could dramatically reduce dementia risk and slow cognitive decline in Alzheimer's patients, offering new hope for millions.